Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Current Deferred Revenue (2016 - 2017)

Innospec's Current Deferred Revenue history spans 8 years, with the latest figure at $100000.0 for Q4 2017.

  • For Q4 2017, Current Deferred Revenue changed 0.0% year-over-year to $100000.0; the TTM value through Dec 2017 reached $100000.0, changed 0.0%, while the annual FY2017 figure was $100000.0, 0.0% changed from the prior year.
  • Current Deferred Revenue for Q4 2017 was $100000.0 at Innospec, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $300000.0 in Q4 2013 and bottomed at $100000.0 in Q1 2013.
  • The 5-year median for Current Deferred Revenue is $200000.0 (2014), against an average of $175000.0.
  • The largest annual shift saw Current Deferred Revenue plummeted 95.45% in 2013 before it soared 200.0% in 2014.
  • A 5-year view of Current Deferred Revenue shows it stood at $300000.0 in 2013, then tumbled by 33.33% to $200000.0 in 2014, then changed by 0.0% to $200000.0 in 2015, then crashed by 50.0% to $100000.0 in 2016, then changed by 0.0% to $100000.0 in 2017.
  • Per Business Quant, the three most recent readings for IOSP's Current Deferred Revenue are $100000.0 (Q4 2017), $100000.0 (Q3 2017), and $100000.0 (Q2 2017).